ID RILP_HUMAN STANDARD; PRT; 401 AA. AC Q96NA2; Q71RE6; Q9BSL3; Q9BYS3; DT 07-FEB-2006 (Rel. 49, Created) DT 07-FEB-2006 (Rel. 49, Last sequence update) DT 07-FEB-2006 (Rel. 49, Last annotation update) DE Rab-interacting lysosomal protein. GN Name=RILP; ORFNames=PP10141; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN LATE ENDOCYTOSIS, RP INTERACTION WITH RAB7, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RC TISSUE=Cervix carcinoma; RX MEDLINE=21099246; PubMed=11179213; DOI=10.1093/emboj/20.4.683; RA Cantalupo G., Alifano P., Roberti V., Bruni C.B., Bucci C.; RT "Rab-interacting lysosomal protein (RILP): the Rab7 effector required RT for transport to lysosomes."; RL EMBO J. 20:683-693(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Kidney; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RX PubMed=15498874; DOI=10.1073/pnas.0404089101; RA Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., RA Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., RA Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., RA Gu J.; RT "Large-scale cDNA transfection screening for genes related to cancer RT development and progression."; RL Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Skeletal muscle; RA Frigimelica E., Lanfranchi G.; RT "Study of 100 skeletal muscle full length mRNA (Telethon project RT B41)."; RL Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain, Lung, Testis, and Uterus; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). RN [6] RP TISSUE SPECIFICITY. RX PubMed=11520070; DOI=10.1006/bbrc.2001.5466; RA Bucci C., De Gregorio L., Bruni C.B.; RT "Expression analysis and chromosomal assignment of PRA1 and RILP RT genes."; RL Biochem. Biophys. Res. Commun. 286:815-819(2001). RN [7] RP FUNCTION IN DYNEIN-DYNACTIN COMPLEX RECRUITMENT. RX MEDLINE=21553057; PubMed=11696325; DOI=10.1016/S0960-9822(01)00531-0; RA Jordens I., Fernandez-Borja M., Marsman M., Dusseljee S., Janssen L., RA Calafat J., Janssen H., Wubbolts R., Neefjes J.; RT "The Rab7 effector protein RILP controls lysosomal transport by RT inducing the recruitment of dynein-dynactin motors."; RL Curr. Biol. 11:1680-1685(2001). RN [8] RP INTERACTION WITH RAB34. RX PubMed=12475955; DOI=10.1091/mbc.E02-05-0280; RA Wang T., Hong W.; RT "Interorganellar regulation of lysosome positioning by the Golgi RT apparatus through Rab34 interaction with Rab-interacting lysosomal RT protein."; RL Mol. Biol. Cell 13:4317-4332(2002). RN [9] RP FUNCTION IN PHAGOSOME MIGRATION AND PHAGOLYSOSOMAL FUSION, AND RP SUBCELLULAR LOCATION. RX PubMed=12944476; DOI=10.1128/MCB.23.18.6494-6506.2003; RA Harrison R.E., Bucci C., Vieira O.V., Schroer T.A., Grinstein S.; RT "Phagosomes fuse with late endosomes and/or lysosomes by extension of RT membrane protrusions along microtubules: role of Rab7 and RILP."; RL Mol. Cell. Biol. 23:6494-6506(2003). RN [10] RP FUNCTION IN LYSOSOMAL MORPHOLOGY AND DISTRIBUTION, INTERACTIONS WITH RP RAB7 AND RAB34, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=14668488; DOI=10.1091/mbc.E03-06-0413; RA Wang T., Wong K.K., Hong W.; RT "A unique region of RILP distinguishes it from its related proteins in RT its regulation of lysosomal morphology and interaction with Rab7 and RT Rab34."; RL Mol. Biol. Cell 15:815-826(2004). RN [11] RP SUBUNIT. RX PubMed=15996637; DOI=10.1016/j.bbrc.2005.06.067; RA Colucci A.M.R., Campana M.C., Bellopede M., Bucci C.; RT "The Rab-interacting lysosomal protein, a Rab7 and Rab34 effector, is RT capable of self-interaction."; RL Biochem. Biophys. Res. Commun. 334:128-133(2005). RN [12] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 244-308 IN COMPLEX WITH RAB7, RP SUBUNIT, AND MUTAGENESIS OF PHE-248; ILE-251; LEU-252; ARG-255; RP LEU-258; LYS-304; MET-305 AND LEU-306. RX PubMed=15933719; DOI=10.1038/sj.emboj.7600643; RA Wu M., Wang T., Loh E., Hong W., Song H.; RT "Structural basis for recruitment of RILP by small GTPase Rab7."; RL EMBO J. 24:1491-1501(2005). CC -!- FUNCTION: Rab effector playing a role in late endocytic transport CC to degradative compartments. Involved in the regulation of CC lysosomal morphology and distribution. Induces recruitment of CC dynein-dynactin motor complexes to Rab7-containing late endosome CC and lysosome compartments. Promotes centripetal migration of CC phagosomes and the fusion of phagosomes with the late endosomes CC and lysosomes. CC -!- SUBUNIT: Homodimer. Each subunit can interact with either RAB7 or CC RAB34. CC -!- SUBCELLULAR LOCATION: Cytoplasmic; associated with late endosomal, CC lysosomal and phagosomal membranes. The interaction with RAB7 is CC necessary for its recruitment to phagosomes. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q96NA2-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96NA2-2; Sequence=VSP_016043, VSP_016044; CC -!- TISSUE SPECIFICITY: Ubiquitous. Strongly expressed in fetal heart, CC heart, stomach, spleen, adrenal gland, thyroid gland, salivary CC gland, fetal liver, liver and lung. Poorly expressed in brain. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ404317; CAC33443.1; -; mRNA. DR EMBL; AK055755; BAB71003.1; -; mRNA. DR EMBL; AF370391; AAQ15227.1; -; mRNA. DR EMBL; AJ278711; CAC82174.1; -; mRNA. DR EMBL; BC004961; AAH04961.1; -; mRNA. DR EMBL; BC031621; AAH31621.1; -; mRNA. DR PDB; 1YHN; X-ray; A/B=244-308. DR SMR; Q96NA2; 244-308. DR Ensembl; ENSG00000167705; Homo sapiens. DR HGNC; HGNC:30266; RILP. DR MIM; 607848; gene. KW 3D-structure; Alternative splicing; Coiled coil; Protein transport; KW Transport. FT REGION 272 333 Necessary for the interaction with RAB7 FT and RAB34, lysosomal distribution and FT morphology. FT COILED 75 181 Potential. FT VARSPLIC 1 210 Missing (in isoform 2). FT /FTId=VSP_016043. FT VARSPLIC 211 213 WAT -> MGA (in isoform 2). FT /FTId=VSP_016044. FT MUTAGEN 248 248 F->A: Strongly reduces dimerization and FT localization to late endosomal/lysosomal FT compartments. FT MUTAGEN 251 251 I->A: Abolishes dimerization, interaction FT with RAB7 and localization to late FT endosomal/lysosomal compartments. FT MUTAGEN 252 252 L->A: Abolishes interaction with RAB7 and FT localization to late endosomal/lysosomal FT compartments. FT MUTAGEN 255 255 R->A: Abolishes dimerization, interaction FT with RAB7 and localization to late FT endosomal/lysosomal compartments. FT MUTAGEN 258 258 L->A: Reduces dimerization, interaction FT with RAB7 and localization to late FT endosomal/lysosomal compartments. FT MUTAGEN 304 304 K->A: Abolishes interaction with RAB7 and FT localization to late endosomal/lysosomal FT compartments. FT MUTAGEN 305 305 M->A: Abolishes interaction with RAB7 and FT localization to late endosomal/lysosomal FT compartments. FT MUTAGEN 306 306 L->A: Abolishes interaction with RAB7 and FT localization to late endosomal/lysosomal FT compartments. FT CONFLICT 284 284 G -> S (in Ref. 1). SQ SEQUENCE 401 AA; 44200 MW; 1057A1DAC2FFED94 CRC64; MEPRRAAPGV PGWGSREAAG SASAAELVYH LAGALGTELQ DLARRFGPEA AAGLVPLVVR ALELLEQAAV GPAPDSLQVS AQPAEQELRR LREENERLRR ELRAGPQEER ALLRQLKEVT DRQRDELRAH NRDLRQRGQE TEALQEQLQR LLLVNAELRH KLAAMQTQLR AAQDRERERQ QPGEAATPQA KERARGQAGR PGHQHGQEPE WATAGAGAPG NPEDPAEAAQ QLGRPSEAGQ CRFSREEFEQ ILQERNELKA KVFLLKEELA YFQRELLTDH RVPGLLLEAM KVAVRKQRKK IKAKMLGTPE EAESSEDEAG PWILLSDDKG DHPPPPESKI QSFFGLWYRG KAESSEDETS SPAPSKLGGE EEAQPQSPAP DPPCSALHEH LCLGASAAPE A //